158 related articles for article (PubMed ID: 15140622)
1. Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.
Sima AA
J Neurol Sci; 2004 May; 220(1-2):133-6. PubMed ID: 15140622
[No Abstract] [Full Text] [Related]
2. [Physiological effects of C-peptide].
Tsimaratos M
Nephrologie; 2004; 25(5):155-61. PubMed ID: 15455788
[TBL] [Abstract][Full Text] [Related]
3. C-peptide, Na+,K(+)-ATPase, and diabetes.
Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
[TBL] [Abstract][Full Text] [Related]
4. Type 1 diabetic neuropathy and C-peptide.
Sima AA; Zhang W; Grunberger G
Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372
[TBL] [Abstract][Full Text] [Related]
5. Effects of C-peptide on microvascular blood flow and blood hemorheology.
Forst T; Kunt T
Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
[TBL] [Abstract][Full Text] [Related]
6. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
Ekberg K; Brismar T; Johansson BL; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
[TBL] [Abstract][Full Text] [Related]
7. [Maurice Dérot Prize 2004. Should C-peptide be put in the insulin bottle?].
Vague P
Journ Annu Diabetol Hotel Dieu; 2004; ():231-7. PubMed ID: 15259321
[No Abstract] [Full Text] [Related]
8. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.
Zhang W; Kamiya H; Ekberg K; Wahren J; Sima AA
Diabetes Metab Res Rev; 2007 Jan; 23(1):63-70. PubMed ID: 16845685
[TBL] [Abstract][Full Text] [Related]
9. C-peptide as a therapeutic tool in diabetic nephropathy.
Hills CE; Brunskill NJ; Squires PE
Am J Nephrol; 2010; 31(5):389-97. PubMed ID: 20357430
[TBL] [Abstract][Full Text] [Related]
10. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
Shahid SM; Mahboob T
Pak J Pharm Sci; 2008 Apr; 21(2):172-9. PubMed ID: 18390448
[TBL] [Abstract][Full Text] [Related]
11. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
Kamikawa A; Ishii T; Shimada K; Makondo K; Inanami O; Sakane N; Yoshida T; Saito M; Kimura K
Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079
[TBL] [Abstract][Full Text] [Related]
12. Diabetic nephropathy: introduction.
Breyer MD
Semin Nephrol; 2007 Mar; 27(2):129. PubMed ID: 17418681
[No Abstract] [Full Text] [Related]
13. Biological Activity of c-Peptide in Microvascular Complications of Type 1 Diabetes-Time for Translational Studies or Back to the Basics?
Ryk A; Łosiewicz A; Michalak A; Fendler W
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419247
[TBL] [Abstract][Full Text] [Related]
14. Fighting diabetic kidney disease. The best defense is a good offense--take action now to prevent kidney disease.
Hirsch IB
Diabetes Forecast; 2002 Feb; 55(2):68-70. PubMed ID: 14959672
[No Abstract] [Full Text] [Related]
15. [The kidneys and diabetes].
Rüster C; Sämann A; Wolf G
Dtsch Med Wochenschr; 2008 Sep; 133(37):1848-52. PubMed ID: 18770486
[No Abstract] [Full Text] [Related]
16. C-peptide and diabetic kidney disease.
Brunskill NJ
J Intern Med; 2017 Jan; 281(1):41-51. PubMed ID: 27640884
[TBL] [Abstract][Full Text] [Related]
17. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
18. Current concepts of diabetes mellitus.
Aschner P
Int Ophthalmol Clin; 1998; 38(2):1-10. PubMed ID: 9604734
[No Abstract] [Full Text] [Related]
19. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
Ii M; Nishimura H; Kusano KF; Qin G; Yoon YS; Wecker A; Asahara T; Losordo DW
Circulation; 2005 Jul; 112(1):93-102. PubMed ID: 15983249
[TBL] [Abstract][Full Text] [Related]
20. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus.
Kunt T; Schneider S; Pfützner A; Goitum K; Engelbach M; Schauf B; Beyer J; Forst T
Diabetologia; 1999 Apr; 42(4):465-71. PubMed ID: 10230651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
